Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RA Chem Pharma offered a diverse portfolio of APIs and finished formulations targeting a broad spectrum of indications; the company did not pioneer late-stage innovative clinical programs but had capabilities in custom synthesis, contract research, preclinical and clinical research[1][2][3][5][6]. Highest phase for any proprietary indications is "Pending" (preclinical/registration).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RA Chem Pharma.